---
category: news
title: "Investment fuels AI-driven development of breakthrough genomic medicines"
excerpt: "David Del Bourgo (CEO and co-founder, Whitelab Genomics) has always been passionate about introducing disruptive, innovative technologies to markets. Now he leads Whitelab Genomics as its artificial intelligence (AI) platform powers the development of genomic therapies â€“ an emerging field in which genetic sequences are injected into cells to target and repair damaged genes."
publishedDateTime: 2022-10-12T07:00:00Z
originalUrl: "https://pharmaphorum.com/digital/investment-fuels-ai-driven-development-of-breakthrough-genomic-medicines/"
webUrl: "https://pharmaphorum.com/digital/investment-fuels-ai-driven-development-of-breakthrough-genomic-medicines/"
type: article
quality: 38
heat: 38
published: false

provider:
  name: pharmaphorum
  domain: pharmaphorum.com

topics:
  - AI in Healthcare
  - AI

images:
  - url: "https://pharmaphorum.com/wp-content/uploads/2022/10/iStock-1363666077.jpg"
    width: 1200
    height: 675
    isCached: true

secured: "+TkObbgNS5RoPLIEfUyEgYjb0B60zdxTUHlZRGlDtIEaVg1uTXJ4/7ZrjCfoqE+KlUkyQ3nz1oHv5f5gMCZJdLZOqYGbwmjXWsAgbIbGJXYYhLMUZShFcRB9K7ziDAfqF8ypskYRUZz2p8JshWm7Lm+Gjl2kfs/bqQma7yORi4wvSZNKe2JQGi0/5XNjFtGdxRqsUI6285ihvT0/t81fTGeJIzeTu6LQacaRyYIljiqcPKfgeqEIS3H0BJTcBIQE7Am/QMrIrcmGItWVvShnvnZ/6EiCZp14revyt56TzDOfREbAMt50R0SxVhWtZn5Izsm9px0MhNRv8PRqVphgndnsqtRiou1jAVF6GP0TIZU=;M7dVJ+6/5pNFcB3jiczimg=="
---

